terça-feira, 2 de setembro de 2008

Folha de S.Paulo e Datafolha restauram a geografia em São Paulo

A Folha de S.Paulo publica há cinco domingos, pesquisa do Datafolha e dados demográficos sobre as regiões da cidade de São Paulo. O destaque fica pela reintrodução da geografia em contraposição à definição ideológica de bairros com sotaque carioca. Tudo que é bom seria na zona sul, o que não fosse seria zona norte, leste, oeste etc... A própria Folha, mais Estadão, Vejinha sempre classificavam os Jardins como Zona Sul, o mesmo para o Morumbi e, até o Alto de Pinheiros! O Ipiranga que fica na zona sul era classificado como zona leste. A geografia agradece à Folha de S.Paulo, que aprendeu a não brigar com os mapas.
Agora, será a vez dos cardiologistas brasileiros aprenderem que o Brasil está no Ocidente do planeta. Quem nunca leu "com a ocidentalização dos hábitos dos brasileiros....? "(uma tradução idiota de "life style westernization" aplicada à China, Japão, India).

segunda-feira, 1 de setembro de 2008

Ensaios Clínicos: um site de ensino

Quem acessar o site Ensaios Clínicos verá uma seleção de resumos dos mais relevantes ensaios clínicos publicados ou comentários relacionados à terapêutica. Na faixa ao lado, também é possível acessá-lo. Desde o início do ano utilizo a secção Ensaios Clínicos em Cardiologia para orientar os residentes de Clínica Médica no preparo de seminários sobre terapêutica que ocorrem todas segundas-feiras. Agora, o objetivo é incentivar os residentes a postarem comentários sobre os temas por eles desenvolvidos para permitir um debate público, incluindo obviamente a imensa comunidade extra-universitária. Depois disso, como as apresentações estão cada vez melhores, a intenção será disponibilizar os diapositivos no site para conhecimento geral.

A demografia não perdoa a falta de planejamento

Uma semana fora do ar. Não foi vírus no computador ou no blogueiro, mas o excesso de atividades em reuniões do ELSA, EMMA, relatórios, análises de projetos, preparo de aulas, revisão de manuscritos, enfim a vida acadêmica na sua intensidade máxima.
Hoje, o Estadão discute a questão da saúde em São Paulo, considerada questão eleitoral mais mais crítica. Na verdade, a saúde do paulistano, como a do brasileiro, melhora ano a ano. Todos os indicadores são positivos, mesmo aqueles relacionados a epidemias como a dengue. O que continua muito ruim é a organização do sistema e, a incapacidade do sistema de saúde (vale para todas políticas públicas, principalmente na educação) em se adaptar às mudanças demográficas e epidemiológicas da sociedade brasileira. Hoje, em São Paulo, sobram leitos de pediatria e obstetrícia, mas faltam de clínica médica e ortopedia. A culpa deve ser compartilhada tanto pelo SUS como pelas escolas médicas.

Anemia e mortalidade

J Am Coll Cardiol, 2008; 52:818-827, doi:10.1016/j.jacc.2008.04.061
Anemia and Mortality in Heart Failure Patients
A Systematic Review and Meta-Analysis Hessel F. Groenveld, MD*, James L. Januzzi, MD, FACC, Kevin Damman, MD*, Jan van Wijngaarden, MD, PhD, Hans L. Hillege, MD, PhD*, Dirk J. van Veldhuisen, MD, PhD, FACC* and Peter van der Meer, MD, PhD,*
*(Email: pvandermeer@partners.org
Objectives: The aim of this study was to assess the effect of anemia on mortality in chronic heart failure (CHF).
Background: Anemia is frequently observed in patients with CHF, and evidence suggests that anemia might be associated with an increased mortality.
Methods: A systematic literature search in MEDLINE (through November 2007) for English language articles was performed. In addition, a manual search was performed. We included cohort studies and retrospective secondary analyses of randomized controlled trials whose primary objective was to analyze the association between anemia and mortality in CHF. Of a total of 1,327 initial studies, we included 34 studies, comprising 153,180 patients. Information on study design, patient characteristics, outcome, and potential confounders were extracted.
Results: Anemia was defined by criteria used in the original articles. Of the 153,180 CHF patients, 37.2% were anemic. After a minimal follow-up of 6 months, 46.8% of anemic patients died compared with 29.5% of nonanemic patients. Crude mortality risk of anemia was odds ratio 1.96 (95% confidence interval: 1.74 to 2.21, p < 0.001). Lower baseline hemoglobin values were associated with increased crude mortality rates (r = –0.396, p = 0.025). Adjusted hazard ratios showed an increased adjusted risk for anemia (hazard ratio 1.46 [95% confidence interval: 1.26 to 1.69, p < 0.001]). Subgroup analysis showed no significant difference between mortality risk of anemia in diastolic or systolic CHF.
Conclusions: Anemia is associated with an increased risk of mortality in both systolic and diastolic CHF. Anemia should, therefore, be considered as a useful prognosticator, and therapeutic strategies aimed to increase hemoglobin levels in CHF should be investigated.
Key Words: heart failure • anemia • prognosis

Cardiopatia diabética

Diabetic Cardiomyopathy: Insights into Pathogenesis, Diagnostic Challenges, and Therapeutic Options
Ashish Aneja MDa, W.H. Wilson Tang MDb, Sameer Bansilal MDa, Mario J. Garcia MDa and Michael E. Farkouh MD, MSca, ,
aThe Mount Sinai Cardiovascular Institute, New York, NY bSection of Heart Failure, Department of Cardiology, Cleveland Clinic, Ohio
Am J Medicine.
Abstract
Diabetic cardiomyopathy is the presence of myocardial dysfunction in the absence of coronary artery disease and hypertension. Hyperglycemia seems to be central to the pathogenesis of diabetic cardiomyopathy and to trigger a series of maladaptive stimuli that result in myocardial fibrosis and collagen deposition. These processes are thought to be responsible for altered myocardial relaxation characteristics and manifest as diastolic dysfunction on imaging. Sophisticated imaging technologies also have permitted the detection of subtle systolic dysfunction in the diabetic myocardium. In the early stages, these changes appear reversible with tight metabolic control, but as the pathologic processes become organized, the changes are irreversible and contribute to an excess risk of heart failure among diabetic patients independently of common comorbidities, such as coronary artery disease and hypertension. Therapeutic agents specifically targeting processes that lead to these pathophysiologic changes are in the early stages of development. Although glycemic control and early administration of neurohormonal antagonists remain the cornerstones of therapeutic approaches, newer treatment targets are currently being explored.

Ocupação e Diabetes

Occupation-Related Differences in the Prevalence of Metabolic Syndrome
Miguel-Angel Sánchez-Chaparro, MD1,2, Eva Calvo-Bonacho, MD1, Arturo González-Quintela, MD3, Carlos Fernández-Labandera, MD1, Martha Cabrera, MD1, Juan-Carlos Sáinz, MD1, Ana Fernández-Meseguer, MD1, José R. Banegas, MD4, Luis-Miguel Ruilope, MD5, Pedro Valdivielso, MD2, Javier Román-García, MD1 on behalf of the Ibermutuamur Cardiovascular Risk Assessment (ICARIA) Study Group
miguelangelsanchez@ibermutuamur.es
Diabetes Care, 08/29/08
OBJECTIVE—To investigate the prevalence of metabolic syndrome in the Spanish working population and determine how the prevalence varies according to occupation and sex.
RESEARCH DESIGN AND METHODS—This was a cross-sectional study of 259,014 workers (mean age 36.4 years, range [16–74]; 72.9% male) who underwent a routine medical checkup. The Adult Treatment Panel III (2001) definition for metabolic syndrome was used.
RESULTS—The prevalence of metabolic syndrome was 11.6% (95% CI 11.5–11.7) in male subjects and 4.1% (4.0–4.2) in female subjects and increased with age. The prevalence of metabolic syndrome varied in the different categories of occupational activity depending on the sex considered. Among female subjects, the age-adjusted prevalence of metabolic syndrome was higher in blue-collar than in white-collar workers, but this difference was not evident among male workers.
CONCLUSIONS—The prevalence of metabolic syndrome varies in the different categories of occupational activity in the Spanish working population. This variation also depends on sex

Oxidação, diabetes, doença coronariana

Oxidation, Type 2 Diabetes, and Coronary Heart Disease: A Complex Interaction
Findings from a population-based study.
Saverio Stranges, MD, PHD1,2, Joan M. Dorn, PHD2, Richard P. Donahue, PHD2, Richard W. Browne, PHD3, Jo L. Freudenheim, PHD2, Kathleen M. Hovey, MSC2 and Maurizio Trevisan, MD, MSC2
OBJECTIVE—The purpose of this study was to analyze the interrelationship among oxidation, myocardial infarction (MI), and type 2 diabetes in a population-based case-control study of MI.
RESEARCH DESIGN AND METHODS—Participants were 1,709 individuals from western New York: 257 women and men with incident MI and 1,452 healthy control subjects (aged 35–70 years). Lipid peroxidation was measured by plasma levels of thiobarbituric acid reactive substances (TBARS). History of type 2 diabetes was determined by self-reported history of medical diagnosis.
RESULTS—In multivariate analyses, there was no significant difference in TBARS levels between case and control subjects in both sexes. In subgroup analyses by diabetes status, diabetic subjects, regardless of MI status, exhibited significantly higher TBARS values than nondiabetic subjects. For diabetic women, TBARS values were 1.84 and 1.83 nmol/ml for case and control subjects, respectively. Values for nondiabetic women were 1.29 and 1.31 nmol/ml, respectively. In diabetic men, values were 1.65 and 1.97 nmol/ml for case and control subjects, respectively. Values for nondiabetic men were 1.36 and 1.36 nmol/ml, respectively.
CONCLUSIONS—Whereas type 2 diabetes may be an important correlate of lipid peroxidation, clinical coronary heart disease may not.